Reyvow

Definition

Reyvow (lasmiditan) is a medication used for the acute treatment of migraine headaches in adults. It acts as a serotonin (5-HT1F) receptor agonist to alleviate migraine symptoms.

5 Must Know Facts For Your Next Test

1. Reyvow is not used for the prevention of migraines but rather for acute treatment.
2. It is a serotonin (5-HT1F) receptor agonist, distinct from triptans which target 5-HT1B/1D receptors.
3. Common side effects include dizziness, fatigue, and paresthesia.
4. It should not be taken with alcohol or other CNS depressants due to increased risk of sedation.
5. Patients are advised to avoid driving or operating machinery for at least eight hours after taking Reyvow.

Review Questions

• What class of drug does Reyvow belong to?
• What are common side effects associated with Reyvow?
• Why is it important for patients to avoid certain activities after taking Reyvow?

Related terms

Triptans: A class of drugs commonly used for the acute treatment of migraines by targeting serotonin receptors (5-HT1B/1D).

CGRP Antagonists: Medications that inhibit calcitonin gene-related peptide, a molecule involved in migraine pathophysiology.

Ergot Alkaloids: Older class of drugs used for migraine relief that constrict blood vessels and affect serotonin receptors.